← 產業報告目錄
Allergy Immunotherapy Market Size, Share & Trends Analysis Report by Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-15頁數 180報告編號 INSIGHTACE-3dec014d38
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 1.9 Billion, the global Allergy Immunotherapy Market is projected to progress to USD 4.3 Billion by 2034, demonstrating a CAGR of 8.5% during the 2025–2034 forecast window.
Allergy Immunotherapy covers The rising incidence of allergic conditions such as allergic rhinitis, asthma, and atopic dermatitis has propelled the demand for allergy immunotherapy. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is propelled by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Allergy Immunotherapy Market Snapshot
Chapter 4. Global Allergy Immunotherapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Industry
Chapter 5. Market Segmentation 1: By Treatment Type Estimates & Trend Analysis
5.1. By Treatment Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Treatment Type:
5.2.1. Subcutaneous Immunotherapy (SCIT)
5.2.2. Sublingual Immunotherapy (SLIT)
5.2.2.1. Tablets
5.2.2.2. Drops
Chapter 6. Market Segmentation 2: By Allergy Type Estimates & Trend Analysis
6.1. By Treatment Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Allergy Type:
6.2.1. Allergic rhinitis
6.2.2. Allergic asthma
6.2.3. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Treatment Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy
7.2.3. Online Pharmacy
Chapter 8. Allergy Immunotherapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Treatment Type, 2021-2034
8.1.2. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.1.3. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.1.4. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.2.2. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.2.3. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.2.4. Europe Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.3.2. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.3.3. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.3.4. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.4.2. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.4.3. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.4.4. Latin America Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, (US$ Million)
8.5.2. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.5.3. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.5.4. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ASIT Biotech
9.2.2. Circassia
9.2.3. Mylan N.V.
9.2.4. Adamis Pharmaceuticals Corporation
9.2.5. Merck KGaA
9.2.6. Stallergenes Greer plc
9.2.7. Allergy Therapeutics
9.2.8. ALK-Abelló A/S
9.2.9. DESENTUM OY
9.2.10. HAL Allergy B.V.
9.2.11. HollisterStier Allergy
9.2.12. LETIPharma
9.2.13. DBV Technologies SA
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們